PTC Therapeutics, Inc.
PTCT
$73.46
-$1.56-2.08%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -100.32% | -104.85% | 114.90% | 34.61% | 1,046.28% |
| Total Depreciation and Amortization | 113.45% | 90.75% | 71.28% | 8.05% | -86.96% |
| Total Amortization of Deferred Charges | 2.01% | 1.95% | 1.67% | 2.37% | 1.01% |
| Total Other Non-Cash Items | 1.70% | 53.19% | -166.97% | -51.41% | -7.38% |
| Change in Net Operating Assets | -163.06% | 149.09% | -963.26% | -49.58% | -164.24% |
| Cash from Operations | -106.79% | -14.23% | 13.89% | 18.36% | 1,129.64% |
| Capital Expenditure | 30.57% | 36.98% | -559.96% | -117.86% | 82.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 49.35% | -86.60% | -578.61% | -315.15% | -73.44% |
| Cash from Investing | 49.16% | -87.30% | -578.67% | -540.15% | -60.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -59.35% | 136.12% | 2,837.17% | -15.54% | 675.91% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -100.00% | -- |
| Cash from Financing | -31.96% | 1,042.78% | 186.34% | -98.39% | 1,642.59% |
| Foreign Exchange rate Adjustments | -128.26% | 213.20% | -170.99% | 361.96% | 365.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -121.11% | 22.11% | -169.33% | -545.34% | 1,634.23% |